NFE2L2 and hepatocellular carcinoma: Our prior studies have shown that a lack of PRDX6 diminishes NRF2 levels in the SNU475 cell line and alters redox proteome in the HepG2 hepatocellular carcinoma cell line leading to decreased cell proliferation by repression of cell cycle progression [21,22].